Literature DB >> 33639058

Pathogenesis of Diabetic Cardiomyopathy and Role of miRNA.

Uzair Ahmed1, Saba Khaliq2, Hafiz Usman Ahmad2, Imtiaz Ahmad3, Usman Ali Ashfaq4, Muhammad Qasim4, Muhammad Shareef Masoud4.   

Abstract

Diabetic cardiomyopathy is characterized as abnormal function and structure of myocardium associated with diabetes irrespective of other cardiac risk factors like hypertension or coronary artery disease (CAD). The pathogenesis of DCM was not well understood in the past due to its complexity but it has been discovered recently. Various factors are found to be associated with the onset of DCM including impaired calcium handling, remodeling of extracellular matrix (ECM), increased oxidative stress, altered metabolism, mitochondrial dysfunction, and endothelial dysfunction. Micro-RNAs (miRNAs) are also found to be of great importance in the pathogenesis of DCM. Different miRNAs like miR-126, miR-24, miR-1, miR-155, miR-499, and miR-199a are found to be associated with different types of heart diseases like CAD and myocardial infarction. Studies have shown that the miRNA plays a crucial role in the development of DCM and it was found that the expression levels of different miRNAs differ in patients as compared to healthy individuals. This review focuses on the pathogenesis of DCM and various factors involved in the onset of diabetic car-diomyopathy. Moreover, the probable role of miRNA in the pathogenesis of DCM is also discussed.

Entities:  

Year:  2021        PMID: 33639058     DOI: 10.1615/CritRevEukaryotGeneExpr.2021037533

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  3 in total

1.  Genetic Variants of MIR27A, MIR196A2 May Impact the Risk for the Onset of Coronary Artery Disease in the Pakistani Population.

Authors:  Taqweem Ul Haq; Abdul Zahoor; Yasir Ali; Yangchao Chen; Fazal Jalil; Aftab Ali Shah
Journal:  Genes (Basel)       Date:  2022-04-24       Impact factor: 4.141

2.  Endothelial derived miRNA-9 mediated cardiac fibrosis in diabetes and its regulation by ZFAS1.

Authors:  Biao Feng; Jieting Liu; Eric Wang; Zhaoliang Su; Subrata Chakrabarti
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

Review 3.  Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy.

Authors:  Jaqueline S da Silva; Renata G J Gonçalves; Juliana F Vasques; Bruna S Rocha; Bianca Nascimento-Carlos; Tadeu L Montagnoli; Rosália Mendez-Otero; Mauro P L de Sá; Gisele Zapata-Sudo
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.